Retrieved 2021-04-16
Recent studies have explored small-molecule inducers, selenium-based compounds, and targeted nanodelivery approaches to restore GPX4 function or mimic its antioxidant capacity in ferroptosis-prone diseases, with therapeutic implications for OA and beyond ( In summary, GPX4 acts not only as a terminal antioxidant enzyme but also as a hub that integrates transcriptional, post-transcriptional, and nutritional cues
Chronic obstructive pulmonary disease and the airway microbiome: what respirologists need to know
According to the Journal of Biomaterials Science , controlled studies on aged skin have shown that the tripeptide may reduce the appearance of fine lines and wrinkles
Regular treatment should reduce symptoms such as headaches, tiredness, lack of energy and breathlessness
Canada becomes the first G7 country to approve a generic version of semaglutide